top of page

Preliminary Program

 

Invited speakers:

 

Adrienne Fairhall - University of Washington

Ester Miyuki Nakamura-Palacios - Federal University of Espírito Santo

Jacinta O'Shea - University of Oxford

Patrick Kwan - Monash University

 

Oral sessions:

For this edition of the BRAINN congress, we selected the platforms (oral presentations) according to the scores provided by our scientific committee. 

​

 

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

 

 

 

 

 

Monday - March 30th 2020

 

09:00 - 09:30    Registration

09:30 - 10:00    Opening Ceremony

10:00 - 11:00    Invited talk - Ester Miyuki Nakamura-Palacios

11:00 - 11:30    Coffee break

11:30 - 12:00    Oral Session I

12:00 - 12:30    Oral Poster Previews I

12:30 - 14:30    Lunch

14:30 - 15:30    Oral session II

15:30 - 16:30    Poster session I

16:30 - 17:00    Coffee break

17:00 - 18:00    Poster session I

 

 

Tuesday - March 31st 2020

 

08:30 - 09:00    Registration

09:00 - 10:00    Invited Talk - Adrienne Fairhall

10:00 - 11:00    Oral Session V

11:00 - 11:30    Coffee break

11:30 - 12:00    Oral Session IV

12:00 - 12:30    Oral Poster Previews II

12:30 - 14:30    Lunch

14:30 - 15:00    Agilent Technologies

14:30 - 16:00    Sil Life / Qiagen

15:30 - 16:30    Poster session II

16:30 - 17:00    Coffee break

17:00 - 18:00    Poster Session II

​

 

 

Wednesday - April 1st 2020

 

08:30 - 09:00    Registration

09:00 - 10:00    Oral session V

10:00 - 11:00    Invited Talk - Patrick Kwan

11:00 - 11:30    Coffee break

11:30 - 11:45    Epistemic

11:45 - 12:00    Best paper awards / Closing ceremony  

12:30 - 13:30    Brunch

​

​

Preliminary_program_7TH-BRAINN.PNG

Confirmed Speakers

Monday - March 30th 2020
ESTER MIYUKI NAKAMURA-PALACIOS_edited.pn

ESTER MIYUKI NAKAMURA-PALACIOS

Federal University of Espírito Santo

Medical Doctor degree from Federal University of Uberlândia (UFU-MG), Master's Degree in Psychopharmacology and PhD in Psychobiology from the Federal University of São Paulo (UNIFESP), Post-Doctorate in Therapeutic and Behavioral Pharmacology from the Louisiana State University Health Science Center. She is currently a Full Professor at the Federal University of Espírito Santo - ES and works in the area of Neurosciences, with emphasis on Cognitive Sciences and Neuropsychopharmacology, mainly in the following subjects: Pre Frontal Cortex, Working Memory, Executive Functions, Cognitive Disorders, Substance Use Disorder, ERP (Event Related Potentials), Neuromodulation by Non-Invasive Brain Stimulation (Transcranial and Epidural), and more recently has invested in the joint elaboration (engineering and psychology) of a Neurofeedback system for application in neurobehavioral disorders.

Tuesday - March 31st 2020
ADRIENNE FAIRHALL.jpg

ADRIENNE FAIRHALL

University of Washington

Adrienne holds a first class honors degree in theoretical physics, working with Bob Dewar in plasma physics, from ANU in Canberra, Australia and completed her PhD in physics at the Weizmann Institute, with Itamar Procaccia working on turbulence, in 1998. She moved into neuroscience research as a postdoc with Bill Bialek at NEC Research Institute in Princeton, then with Michael Berry at Princeton University. She joined the faculty of UW’s Department of Physiology and Biophysics in 2004 and became a co-director of the WRF Institute for Neuroengineering in 2014. With Eric Shea-Brown, she co-directs the Computational Neuroscience Center’s research and educational program at UW. 

Wednesday - April 1st 2020
Patrick Kwan_edited.jpg

PATRICK KWAN

Monash University

Patrick is a Professor in the Van Cleef Centre for Nervous Diseases, Department of Neuroscience, within the Central Clinical School, and Consultant Neurologist and Head of the Epilepsy Clinic at Alfred Health.
He is a medical specialist in neurology and an international authority in epileptology and antiepileptic drug development. 
Professor Kwan’s research portfolio encompasses both applied basic science and clinical aspects to improve the treatment outcomes of epilepsy. His research is focused on understanding the effects of long term treatment, identifying factors that affect outcomes, mechanisms of drug resistance, identifying novel molecular targets for the treatment and prevention of epilepsy and translating research findings into the practice of personalized medicine for epilepsy.

TALK: “When state-of-the-art is not good enough: strategies to improve epilepsy outcomes” 

bottom of page